SUPN vs. LSCC

Last updated Apr 1, 2026

Compare and contrast key facts about Supernus Pharmaceuticals, Inc. (SUPN) and Lattice Semiconductor Corporation (LSCC).

Performance

SUPN vs. LSCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Supernus Pharmaceuticals, Inc. (SUPN) and Lattice Semiconductor Corporation (LSCC). The values are adjusted to include any dividend payments, if applicable.

SUPN vs. LSCC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SUPN Supernus Pharmaceuticals, Inc.	4.00%	37.44%	24.95%	-18.87%	22.33%	15.90%	6.07%	-28.60%	-16.64%	57.82%
LSCC Lattice Semiconductor Corporation	26.07%	29.89%	-17.89%	6.33%	-15.81%	68.18%	139.39%	176.59%	19.72%	-21.47%

Fundamentals

Market Cap SUPN : $2.96B LSCC : $12.68B
EPS SUPN : -$72.82 LSCC : $0.02
PS Ratio SUPN : 0.01 LSCC : 24.37
PB Ratio SUPN : 0.00 LSCC : 18.29
Total Revenue (TTM) SUPN : $212.08B LSCC : $523.26M
Gross Profit (TTM) SUPN : $361.70B LSCC : $356.94M
EBITDA (TTM) SUPN : -$3.92B LSCC : $45.55M

Returns By Period

In the year-to-date period, SUPN achieves a 4.00% return, which is significantly lower than LSCC's 26.07% return. Over the past 10 years, SUPN has underperformed LSCC with an annualized return of 12.30%, while LSCC has yielded a comparatively higher 32.43% annualized return.

SUPN

• 1D: 4.74%
• 1M: -5.55%
• YTD: 4.00%
• 6M: 8.16%
• 1Y: 57.83%
• 3Y*: 12.58%
• 5Y*: 14.11%
• 10Y*: 12.30%

LSCC

• 1D: 8.72%
• 1M: -2.99%
• YTD: 26.07%
• 6M: 26.51%
• 1Y: 76.85%
• 3Y*: -0.97%
• 5Y*: 13.76%
• 10Y*: 32.43%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SUPN vs. LSCC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SUPN

SUPN Risk / Return Rank: 83
SUPN Sharpe Ratio Rank: 86
SUPN Sortino Ratio Rank: 79
SUPN Omega Ratio Rank: 84
SUPN Calmar Ratio Rank: 83
SUPN Martin Ratio Rank: 81

LSCC

LSCC Risk / Return Rank: 80
LSCC Sharpe Ratio Rank: 80
LSCC Sortino Ratio Rank: 78
LSCC Omega Ratio Rank: 78
LSCC Calmar Ratio Rank: 81
LSCC Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SUPN vs. LSCC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Supernus Pharmaceuticals, Inc. (SUPN) and Lattice Semiconductor Corporation (LSCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SUPN	LSCC	Difference
Sharpe ratio Return per unit of total volatility	1.61	1.24	+0.38
Sortino ratio Return per unit of downside risk	2.09	1.97	+0.12
Omega ratio Gain probability vs. loss probability	1.32	1.27	+0.06
Calmar ratio Return relative to maximum drawdown	2.66	2.38	+0.28
Martin ratio Return relative to average drawdown	6.49	7.14	-0.65
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SUPN vs. LSCC - Sharpe Ratio Comparison

The current SUPN Sharpe Ratio is 1.61, which is higher than the LSCC Sharpe Ratio of 1.24. The chart below compares the historical Sharpe Ratios of SUPN and LSCC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SUPN	LSCC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.61	1.24	+0.38
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.39	0.26	+0.14
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.28	0.64	-0.36
Sharpe Ratio (All Time) Calculated using the full available price history	0.30	0.20	+0.10

Correlation

The correlation between SUPN and LSCC is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SUPN vs. LSCC - Dividend Comparison

Neither SUPN nor LSCC has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

SUPN vs. LSCC - Drawdown Comparison

The maximum SUPN drawdown since its inception was -75.86%, smaller than the maximum LSCC drawdown of -97.34%. Use the drawdown chart below to compare losses from any high point for SUPN and LSCC.

Drawdown Indicators

	SUPN	LSCC	Difference
Max Drawdown Largest peak-to-trough decline	-75.86%	-97.34%	+21.48%
Max Drawdown (1Y) Largest decline over 1 year	-22.60%	-28.50%	+5.90%
Max Drawdown (5Y) Largest decline over 5 years	-45.94%	-61.09%	+15.15%
Max Drawdown (10Y) Largest decline over 10 years	-75.86%	-61.09%	-14.77%
Current Drawdown Current decline from peak	-13.63%	-12.30%	-1.33%
Average Drawdown Average peak-to-trough decline	-37.00%	-55.42%	+18.42%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.26%	9.49%	-0.23%

Volatility

SUPN vs. LSCC - Volatility Comparison

The current volatility for Supernus Pharmaceuticals, Inc. (SUPN) is 10.18%, while Lattice Semiconductor Corporation (LSCC) has a volatility of 22.11%. This indicates that SUPN experiences smaller price fluctuations and is considered to be less risky than LSCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SUPN	LSCC	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.18%	22.11%	-11.93%
Volatility (6M) Calculated over the trailing 6-month period	28.47%	40.40%	-11.93%
Volatility (1Y) Calculated over the trailing 1-year period	36.06%	62.74%	-26.68%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.95%	53.93%	-17.98%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	43.89%	50.61%	-6.72%

Financials